Curated News
By: NewsRamp Editorial Staff
November 06, 2025

Datavault AI & Scilex Partner on $2.55B Biotech Tokenization Deal

View History of this news story on GitHub
Original Source

TLDR

  • Datavault AI's exclusive license with Scilex creates a first-mover advantage in the $2 trillion biotech tokenization market with potential for $2.55 billion in milestone payments.
  • Datavault AI's technology enables tokenization of biotech assets through AI-driven blockchain solutions, creating exchange platforms for genomic data and pharmaceutical information.
  • This technology enables biotech companies to access non-dilutive funding, accelerating medical research and drug development for better healthcare outcomes worldwide.
  • Datavault AI's deal combines AI, blockchain, and biotech to create digital twins of pharmaceutical assets, revolutionizing how medical data is valued and traded.

Impact - Why it Matters

This partnership represents a transformative moment for the biotech and pharmaceutical industries, potentially revolutionizing how valuable medical data and intellectual property are monetized and traded. For patients and healthcare consumers, this could accelerate drug discovery and development by creating new funding mechanisms for research. The tokenization of genomic data and drug information creates unprecedented opportunities for data sharing while maintaining security through blockchain technology. This development matters because it addresses the critical funding gap in biotech research while creating new paradigms for data ownership and value creation in healthcare. The $2 trillion market opportunity indicates this could become a standard practice across the pharmaceutical industry, potentially lowering drug development costs and speeding up the delivery of new treatments to market.

Summary

Datavault AI (NASDAQ: DVLT), a pioneering company in AI-driven blockchain solutions, has granted Scilex Holding Company an exclusive worldwide license to deploy its proprietary technology specifically within the biotech and biopharma sectors. This landmark agreement enables Scilex to build and operate a revolutionary Biotech Exchange platform that will tokenize, trade, and monetize critical biotech assets including genomic data, diagnostics, and drug information. The deal represents a significant financial commitment, featuring a $10 million upfront payment structured in four installments and potential milestone payments reaching up to $2.55 billion, supported by Datavault AI's extensive patent portfolio and proven high-performance computing expertise.

The strategic partnership positions Datavault AI to expand its technology into a comprehensive Pharmaceutical Exchange platform, targeting an estimated $2 trillion market opportunity that could fundamentally transform how biotech companies access non-dilutive funding. As a leader in AI experience, valuation, and asset monetization within the Web 3.0 environment, Datavault AI's cloud-based platform offers comprehensive solutions through its Acoustic Science and Data Science Divisions. The company's Information Data Exchange (IDE) technology enables Digital Twins and licensing of name, image, and likeness by securely connecting physical real-world objects to immutable metadata objects, fostering responsible AI with integrity across multiple industries including sports & entertainment, biotech, education, fintech, and healthcare.

To view the full press release, visit the provided link for comprehensive details about this groundbreaking partnership. Datavault AI's headquarters in Beaverton, OR serves as the central hub for developing these innovative solutions that leverage Web 3.0 and high-performance computing to provide cutting-edge tools for experiential data perception, valuation, and secure monetization. The company's completely customizable technology suite offers AI and Machine Learning automation, third-party integration, detailed analytics, marketing automation, and advertising monitoring capabilities that position it at the forefront of the digital transformation revolution across multiple sectors.

Source Statement

This curated news summary relied on content disributed by NewMediaWire. Read the original source here, Datavault AI & Scilex Partner on $2.55B Biotech Tokenization Deal

blockchain registration record for this content.